Cambridge Consultants has developed a public blockchain trading platform for drug price negotiation. The platform uses smart contracts on the Ethereum blockchain to enable and authorise trades, including contracts for FDA approvals. The aim is to create a transparent system that benefits all stakeholders, from pharmaceutical companies to patients, by fostering price competition and improving access to drugs.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
